Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, China.
Department of Oncology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, China.
Biomed Res Int. 2019 May 22;2019:2741598. doi: 10.1155/2019/2741598. eCollection 2019.
This study constructs, calibrates, and verifies a mathematical simulation model designed to project the natural history of ESCC and is intended to serve as a platform for testing the benefits and cost-effectiveness of primary and secondary ESCC prevention alternatives.
The mathematical model illustrates the natural history of ESCC as a sequence of transitions among health states, including the primary health states (e.g., normal mucosa, precancerous lesions, and undetected and detected cancer). Using established calibration approaches, the parameter sets related to progression rates between health states were optimized to lead the model outputs to match the observed data (specifically, the prevalence of precancerous lesions and incidence of ESCC from the published literature in Chinese high-risk regions). As illustrative examples of clinical and policy application, the calibrated and validated model retrospectively simulate the potential benefit of two reported ESCC screening programs.
Nearly 1,000 good-fitting parameter sets were identified from 1,000,000 simulated sets. Model outcomes had sufficient calibration fit to the calibration targets. Additionally, the verification analyses showed reasonable external consistency between the model-predicted effectiveness of ESCC screening and the reported data from clinical trials.
This parameterized mathematical model offers a tool for future research investigating benefits, costs, and cost-effectiveness related to ESCC prevention and treatment.
本研究构建、校准和验证了一个旨在预测 ESCC 自然史的数学模拟模型,旨在为原发性和二级 ESCC 预防替代方案的效益和成本效益测试提供平台。
该数学模型将 ESCC 的自然史描述为健康状态之间的一系列转变,包括主要健康状态(例如正常黏膜、癌前病变和未检测到的和已检测到的癌症)。使用已建立的校准方法,优化与健康状态之间进展率相关的参数集,以使模型输出与观察数据相匹配(具体来说,是来自中国高危地区已发表文献中癌前病变的流行率和 ESCC 的发病率)。作为临床和政策应用的说明性示例,校准和验证后的模型回顾性模拟了两项已报道的 ESCC 筛查计划的潜在效益。
从 100 万个模拟集中确定了近 1000 个拟合良好的参数集。模型结果与校准目标有足够的校准拟合度。此外,验证分析表明,模型预测的 ESCC 筛查效果与临床试验报告的数据之间具有合理的外部一致性。
该参数化数学模型为未来研究 ESCC 预防和治疗的效益、成本和成本效益提供了一种工具。